WET ARMD
Anti-VEGF Injections
Until recently, wet ARMD was an untreatable condition. It is only since 2003 that treatments are available, in the form of medications injected into the eye. These medications are known as anti-VEGF (vascular endothelial growth factor) and work against a protein that stimulates new blood vessel growth. By targeting the VEGF, they reduce the growth of the abnormal blood vessels and/or leaking and bleeding. Medications in use include Eylea, Lucentis, Avastin, and Vabysmo, amongst others.
The aim of anti-VEGF treatment is to prevent further damage. However, vision can sometimes even improve. In either case, the sooner you can get treatment, the better the long-term outcome. Timely diagnosis, close monitoring, and prompt treatment give you the best chance of saving your vision. Regular (four-weekly) reviews with imaging and examination are recommended, with injections administered within days if required.
Having an injection
We understand that having ocular injections can seem daunting. Patient comfort matters to us as much as patient safety so, if an injection is needed, Mr Yodaiken will make sure you feel comfortable with the procedure before going ahead.
After your injection, you can expect floaters and some discomfort. In rare cases, there is significant pain, but it usually settles within a day. The eye may be red from the injection and it may take a few days to settle.
For those who are fortunate enough to have an improvement in their vision, this may take a few days to a few months.
You are welcome to contact Mr Yodaiken with any concerns post-injection.
What does the treatment cost?
Initial consultation – £295
OCT scan – £250
Avastin injection, one eye – £1020
Avastin injection, both eyes – £1697
Eylea injection, one eye – £1400
Eylea injection, both eyes – £2200
Lucentis injection, one eye – £2120
Lucentis injection, both eyes – £3904
Vabysmo injection, each – £1900
“The clinic where we care about you as well as for you.”
We Have What You Need
Expertise
Highly experienced consultant ophthalmologist specialising in medical retina.
PERSONAL CARE
The same doctor every time for continuity of care and a good patient doctor relationship.
CLOSE MONITORING
Monthly reviews and regular OCT scanning for early identification of disease progression.
THE LATEST TREATMENTS
Access to new treatments currently in development as soon as they are available.